APP and Alzheimer disease: The β-amyloid precursor protein (APP) that accumulates in vulnerable brain regions in Alzheimer’s disease (AD) can be cleaved in two different pathways: amyloidogenic and nonamyloidogenic pathways, which include three different secretases: α-secretase, β-secretase, and γ-secretase.